31.20
+0.40
+(1.30%)
At close: April 17 at 9:47:21 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | 170.91M | 175.03M | 701.94M | 729.29M |
| Low Estimate | 170M | 173M | 696M | 720.44M |
| High Estimate | 172.4M | 177.4M | 707M | 740M |
| Year Ago Sales | 153.7M | 165.76M | 646.69M | 701.94M |
| Sales Growth (year/est) | 11.19% | 5.59% | 8.54% | 3.90% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| FM5.SG | -- | -- | -- | -- |
| S&P 500 | 6.92% | 4.87% | 8.58% | 14.16% |
Upgrades & Downgrades
| Maintains | Raymond James: Outperform to Outperform | 4/2/2025 |
| Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 1/31/2025 |
| Reiterates | Raymond James: Outperform to Outperform | 1/31/2025 |
| Reiterates | Piper Sandler: Overweight to Overweight | 1/31/2025 |
| Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 12/4/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 10/28/2024 |